Why some doctors go to work for ‘the dark side’; revamped Covid panel argues for research limits

The prior authorization process draws ire from many physicians. But some wind up leaving clinical medicine to work for "the dark side."

March 8, 2023 Check out STAT+

Sponsored By

Aram Boghosian for STAT STAT+ | Many doctors spend their days battling insurers. Why do some go to work for 'the dark side'? The prior authorization process draws ire from many physicians. But some wind up leaving clinical medicine to work for "the dark side." By Trisha Pasricha Revamped Covid panel argues for research limits, even bans Republican lawmakers argue pathogen-altering research should be banned until policymakers and scientists work out its value and risks. By Sarah Owermohle FDA issues rare comment on approval of Covid and flu home test from company that went bankrupt The new details could be a sign that the FDA is becoming more flexible about its requirements for approving at-home flu test kits. By Brittany Trang Photo illustration: Casey Shenery for STAT 'A different type of fatigue': One woman's Parkinson's diagnosis is a test of flexibility and gratitude A New Yorker talks about how she came to realize she had Parkinson's, what she gave up, and what she has not lost. By Isabella Cueto Study of trans men suggests that androgen hormone therapy can lower breast cancer risk Implications, a researcher says, include new treatments for breast cancer and less frequent screening for trans men. By Angus Chen HHS secretary signals support for new restriction on addiction treatment Some addiction experts criticize a DEA proposal limiting access to buprenorphine; Xavier Becerra said it balanced safety and patient needs. By Lev Facher Adobe Opinion: How cross-state licensure reform can ease America's mental health crisis The antiquated system of licensure in the U.S. is creating a huge barrier to realizing the potential of telehealth for mental health care. By Harry Ritter

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2023, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser